Drug Profile
AZD 6088
Alternative Names: AZD6088Latest Information Update: 15 Feb 2010
Price :
$50
*
At a glance
- Originator AstraZeneca
- Class
- Mechanism of Action Muscarinic M1 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Neuropathic pain
Most Recent Events
- 28 Jan 2010 Discontinued - Phase-I for Neuropathic pain in United Kingdom (PO)
- 30 Jun 2009 Phase-I clinical trials in Neuropathic pain in United Kingdom (PO)